Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Collectin-11 promotes cancer cell proliferation and tumor growth
Jia-Xing Wang, Bo Cao, Ning Ma, Kun-Yi Wu, Wan-Bing Chen, Weiju Wu, Xia Dong, Cheng-Fei Liu, Ya-Feng Gao, Teng-Yue Diao, Xiao-Yun Min, Qing Yong, Zong-Fang Li, Wuding Zhou, Ke Li
Jia-Xing Wang, Bo Cao, Ning Ma, Kun-Yi Wu, Wan-Bing Chen, Weiju Wu, Xia Dong, Cheng-Fei Liu, Ya-Feng Gao, Teng-Yue Diao, Xiao-Yun Min, Qing Yong, Zong-Fang Li, Wuding Zhou, Ke Li
View: Text | PDF
Research Article Immunology Oncology

Collectin-11 promotes cancer cell proliferation and tumor growth

  • Text
  • PDF
Abstract

Collectin-11 (CL-11) is a recently described soluble C-type lectin that has distinct roles in embryonic development, host defence, autoimmunity, and fibrosis. Here we report that CL-11 also plays an important role in cancer cell proliferation and tumor growth. Melanoma growth was found to be suppressed in Colec11–/– mice in a s.c. B16 melanoma model. Cellular and molecular analyses revealed that CL-11 is essential for melanoma cell proliferation, angiogenesis, establishment of more immunosuppressive tumor microenvironment, and the reprogramming of macrophages to M2 phenotype within melanomas. In vitro analysis revealed that CL-11 can activate tyrosine kinase receptors (EGFR, HER3) and ERK, JNK, and AKT signaling pathways and has a direct stimulatory effect on murine melanoma cell proliferation. Furthermore, blockade of CL-11 (treatment with L-fucose) inhibited melanoma growth in mice. Analysis of open data sets revealed that COLEC11 gene expression is upregulated in human melanomas and that high COLEC11 expression has a trend toward poor survival. CL-11 also had direct stimulatory effects on human tumor cell proliferation in melanoma and several other types of cancer cells in vitro. Overall, our findings provide the first evidence to our knowledge that CL-11 is a key tumor growth–promoting protein and a promising therapeutic target in tumor growth.

Authors

Jia-Xing Wang, Bo Cao, Ning Ma, Kun-Yi Wu, Wan-Bing Chen, Weiju Wu, Xia Dong, Cheng-Fei Liu, Ya-Feng Gao, Teng-Yue Diao, Xiao-Yun Min, Qing Yong, Zong-Fang Li, Wuding Zhou, Ke Li

×

Figure 6

CL-11 induces mitogenic kinase signaling and stimulates melanoma cell proliferation in vitro.

Options: View larger image (or click on image) Download as PowerPoint
CL-11 induces mitogenic kinase signaling and stimulates melanoma cell pr...
(A) Representative microscopy images showing CL-11 bound to B16 cells. CL-11 (red) and DAPI (blue). Scale bar: 10 μm. (B) Representative microscopy images of EdU staining in B16 cells following the treatment with rCL-11 at the indicated concentrations. EdU (green) and DAPI (blue). Scale bar: 200 μm. (C) Cell proliferation rate and total cell numbers corresponding to the images in B. B and C are representative of 2 independent experiments. Data are expressed as mean ± SEM. (D and E) Additional sets of EdU cell proliferation assay performed using 1,200 ng/mL of rCL-11. (D) Representative microscopy images of EdU staining. Scale bar: 100 μm. (E) Cell proliferation rate and total cell numbers. Data were analyzed by paired t test (5 individual experiments). Each dot represents the average value of the percentages or cell numbers calculated from 5 image fields at 100× for each sample. (F) Left panel: Western blots showing total and phosphorylated ERK (p-ERK), JNK (p-JNK), and AKT (p-AKT) in B16 melanoma cells at the indicated time points following rCL-11 (600 ng/mL) stimulation. Right panel: quantification of phosphorylated proteins relative to their respective total proteins corresponding with the blots. (G) Representative Western blots showing total and p-ERK, p-JNK, and p-AKT in B16 melanoma cells that have been stimulated with rCL-11 at the indicated concentrations for 5 minutes. (H) Quantification of p-ERK, p-JNK, and p-AKT relative to their respective total proteins corresponding to the blots in G. (I) Representative Western blots showing total, p-EGFR, and p-HER3 in B16 cells following the treatment with rCL-11 for 5 minutes. (J) Quantification of p-EGFR and p-HER3 relative to their respective total proteins corresponding with the blots in I. (H and J) Data were analyzed by 1-way ANOVA (5 independent experiments). *P < 0.05; **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts